Gross Margin
19.02%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 22.82%.Updated Jul 19, 2026Profit Margin
4.10%vs Specialty Chemicals peers Updated Jul 19, 2026Operating Margin
5.60%vs Specialty Chemicals peers Updated Jul 19, 2026Return on Assets (TTM)
6.51%vs Specialty Chemicals peers Updated Jul 19, 2026Return on Equity (TTM)
14.70%vs Specialty Chemicals peers Updated Jul 19, 2026Revenue (TTM)
1.88BUSDUpdated Jul 19, 2026Revenue per Share (TTM)
95.57USDUpdated Jul 19, 2026Quarterly Revenue Growth
-0.30%vs Specialty Chemicals peers Updated Jul 19, 2026Gross Profit (TTM)
428.60MUSDUpdated Jul 19, 2026EBITDA (TTM)
281.10MUSDUpdated Jul 19, 2026Net Income (TTM)
77.00MUSDUpdated Jul 19, 2026Quarterly Earnings Growth (YoY)
-0.26%vs Specialty Chemicals peers Updated Jul 19, 2026Operating Cash Flow (TTM)
191.50MUSDUpdated Jul 19, 2026Levered Free Cash Flow (TTM)
130.57MUSDUpdated Jul 19, 2026Forward Annual Dividend Rate
0.3600USDUpdated Jul 19, 2026Forward Annual Dividend Yield
0.73%Updated Jul 19, 2026Trailing Annual Dividend Rate
0.3400USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.69%Updated Jul 19, 20265-Year Average Dividend Yield
2.61%Updated Jul 19, 2026Payout Ratio
8.75%vs Specialty Chemicals peers Updated Jul 19, 2026Minority Interest (Equity)
300.00KUSDFY2025 · Dec 31, 2025Revenue
1.88BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.43BUSDFY2025 · Dec 31, 2025Gross Profit
447.80MUSDFY2025 · Dec 31, 2025Operating Income
219.30MUSDFY2025 · Dec 31, 2025Pre-tax Income
81.20MUSDFY2025 · Dec 31, 2025Income Tax Expense
25.20MUSDFY2025 · Dec 31, 2025Net Income
56.00MUSDFY2025 · Dec 31, 2025EBIT
147.30MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
272.40MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
154.90MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
66.10MUSDFY2025 · Dec 31, 2025EPS (Basic)
2.82USDFY2025 · Dec 31, 2025EPS (Diluted)
2.74USDFY2025 · Dec 31, 2025Basic Shares Outstanding
19.86MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
19.86MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
56.00MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
144.40MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
38.00MUSDFY2025 · Dec 31, 2025Income Tax Paid
9.40MUSDFY2025 · Dec 31, 2025Interest Paid
63.50MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
56.00MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
73.60MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
11.30MUSDFY2025 · Dec 31, 2025Stock-based Compensation
13.80MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-2.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
30.90MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-57.20MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
18.00MUSDFY2025 · Dec 31, 2025Net Acquisitions
-15.90MUSDFY2025 · Dec 31, 2025Other Investing Activity
-1.80MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-17.70MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
558.30MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-571.00MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-38.20MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-6.40MUSDFY2025 · Dec 31, 2025Other Financing Charges
-2.60MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-58.50MUSDFY2025 · Dec 31, 2025